Last reviewed · How we verify
NCT03966534
Blood Test Order and Culture Contamination
NA trial testing Blood diversion in Blood Culture Contamination in 970 participants. Completed in 28 February 2019.
28 February 2019
Quick facts
| Lead sponsor | Shaare Zedek Medical Center |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 970 |
| Start date | 1 September 2018 |
| Primary completion | 28 February 2019 |
| Estimated completion | 28 February 2019 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- Blood diversion
Conditions studied
- Blood Culture Contamination — all drugs for Blood Culture Contamination →
Sponsor
Shaare Zedek Medical Center
Who can join
18 and older, any sex, with Blood Culture Contamination. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A randomized partially controlled study to examine the effect of blood diversion into a heparin lithium tube on the incidence of blood culture contamination.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Modification of Blood Test Draw Order to Reduce Blood Culture Contamination: A Randomized Clinical Trial.
Zimmerman FS, Karameh H, Ben-Chetrit E, Zalut T, et al · · 2020 · cited 16× · PMID 31570942 · DOI 10.1093/cid/ciz971
Verify or expand the search:
- PubMed search for NCT03966534
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Blood Culture Contamination
Currently open trials in the same condition.
- NCT06806709 — Reducing Blood Culture Contamination With the Use of a Needle-less Blood Draw Device (The PIVO Trial) · NA · recruiting
Other Shaare Zedek Medical Center trials
Trials by the same sponsor.
- NCT05331209 — Acupuncture With/Without Self-acupressure for Post-oophorectomy Hot Flashes in BRCA Carriers · NA · not yet recruiting
- NCT06070753 — A Prospective, Trial About Safety and Efficacy of Combined Treatment With Cerebrolysin in Acute Ischemic Hemispheric Str · NA · unknown
- NCT05841953 — The Use of Electrical Stimulation to Increase Anal Pressures · NA · unknown
- NCT06777706 — Open Label Study to Assess Safety & Efficacy of QD for Induction of Remission in Pediatric Patients with UC · NA · completed
- NCT05838105 — Two Different Types of Luteal Phase Support in Natural Cycle Frozen Embryo Transfer and Its Effect on Pregnancy Rates · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03966534 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shaare Zedek Medical Center
- Last refreshed: 29 May 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03966534.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing